Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Hidradenitis suppurativa may be a type of autoinflammatory skin disease linked to gene mutations and immune system issues.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Cataract surgery in Europe varies in frequency and cost between countries.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

The journal covered various dermatology topics, including treatments, disease management, and research findings.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.